Agenus Inc. AGEN | $9.07B | 74.44 | 15.63M | 0% | +$0 | 48.15 | |
Cartesian Therapeutics, Inc. RNAC | $5.94B | 51.34 | 9.14M | 0% | +$0 | 31.54 | |
Lexicon Pharmaceuticals, Inc. LXRX | $282.13M | 32.52 | 117.55M | 0% | +$0 | 1.5 | |
CAVA Group, Inc. CAVA | $1.86B | 23.25 | 26.51M | -17.18% | -$385.28M | 9.86 | |
Scholar Rock Holding Corporation SRRK | $199.97M | 14.12 | 11.26M | 0% | +$0 | 1.06 | |
GlycoMimetics, Inc. GLYC | $25.77M | 13.32 | 8.59M | 0% | +$0 | 0.14 | |
Syros Pharmaceuticals, Inc. SYRS | $13.4M | 9.37 | 2.51M | 0% | +$0 | 0.07 | |
Seer, Inc. SEER | $9.03M | 7.32 | 4.75M | 0% | +$0 | 0.05 | |
Solid Biosciences Inc. SLDB | $33.3M | 6.51 | 2.5M | +174.96% | +$21.19M | 0.18 | |
Silence Therapeutics plc SLN | $60.04M | 5.96 | 2.78M | -7.35% | -$4.76M | 0.32 | |
Gossamer Bio, Inc. GOSS | $15.7M | 5.88 | 13.31M | +10.37% | +$1.47M | 0.08 | |
IGM Biosciences, Inc. IGMS | $29.73M | 5.22 | 3.08M | -0.65% | -$193,000.00 | 0.16 | |
Kymera Therapeutics, Inc. KYMR | $121.69M | 4.93 | 3.03M | +19.61% | +$19.96M | 0.65 | |
Korro Bio, Inc. KRRO | $37.73M | 4.52 | 419,226 | +0.15% | +$55,890.00 | 0.2 | |
Morphic Holding, Inc. MORF | $77.9M | 4.42 | 2.21M | +3.51% | +$2.64M | 0.41 | |
Generation Bio Co. GBIO | $11.52M | 4.26 | 2.83M | +0.58% | +$66,748.00 | 0.06 | |
Ovid Therapeutics Inc. OVID | $7.63M | 3.52 | 2.5M | 0% | +$0 | 0.04 | |
Wave Life Sciences Ltd. WVE | $25M | 3.31 | 4.05M | +34.71% | +$6.44M | 0.13 | |
Elevation Oncology, Inc. ELEV | $7.76M | 2.77 | 1.51M | New | +$7.76M | 0.04 | |
Kura Oncology, Inc. KURA | $40.95M | 2.52 | 1.92M | +8.59% | +$3.24M | 0.22 | |
Arrowhead Pharmaceuticals, Inc. ARWR | $86.85M | 2.45 | 3.04M | +195.32% | +$57.44M | 0.46 | |
Lexeo Therapeutics, Inc. Common Stock LXEO | $12.57M | 2.43 | 801,716 | +32.86% | +$3.11M | 0.07 | |
Acelyrin, Inc. SLRN | $16.23M | 2.43 | 2.41M | -20.78% | -$4.26M | 0.09 | |
Tango Therapeutics, Inc. TNGX | $17.43M | 2.05 | 2.19M | New | +$17.43M | 0.09 | |
Erasca, Inc. ERAS | $9.73M | 1.98 | 4.72M | 0% | +$0 | 0.05 | |
Taysha Gene Therapies, Inc. TSHA | $10.58M | 1.97 | 3.69M | +0.67% | +$70,154.28 | 0.06 | |
SpringWorks Therapeutics, Inc. SWTX | $69.66M | 1.91 | 1.42M | -12.38% | -$9.84M | 0.37 | |
Prothena Corporation plc PRTA | $24.8M | 1.86 | 1M | +99.73% | +$12.38M | 0.13 | |
Neumora Therapeutics, Inc. Common Stock NMRA | $40.21M | 1.83 | 2.92M | +14.55% | +$5.11M | 0.21 | |
Crinetics Pharmaceuticals, Inc. CRNX | $65.09M | 1.76 | 1.39M | New | +$65.09M | 0.35 | |
Astria Therapeutics, Inc. ATXS | $12.45M | 1.61 | 884,214 | New | +$12.45M | 0.07 | |
Dyne Therapeutics, Inc. DYN | $43.09M | 1.56 | 1.52M | +24.63% | +$8.52M | 0.23 | |
Centessa Pharmaceuticals plc CNTA | $15.96M | 1.25 | 1.41M | +39.51% | +$4.52M | 0.09 | |
Tourmaline Bio, Inc. TRML | $7.2M | 1.23 | 314,496 | +243.99% | +$5.11M | 0.04 | |
Apellis Pharmaceuticals, Inc. APLS | $77.31M | 1.08 | 1.32M | -7.46% | -$6.23M | 0.41 | |
Vera Therapeutics, Inc. VERA | $21.82M | 0.93 | 506,019 | New | +$21.82M | 0.12 | |
Edgewise Therapeutics, Inc. EWTX | $14.81M | 0.87 | 811,718 | New | +$14.81M | 0.08 | |
Revolution Medicines, Inc. RVMD | $42.5M | 0.8 | 1.32M | -22.25% | -$12.16M | 0.23 | |
Merus N.V. MRUS | $20.49M | 0.78 | 455,081 | New | +$20.49M | 0.11 | |
Madrigal Pharmaceuticals, Inc. MDGL | $29.51M | 0.52 | 110,507 | New | +$29.51M | 0.16 | |
Cytokinetics, Incorporated CYTK | $35.52M | 0.44 | 506,584 | -58.28% | -$49.62M | 0.19 | |
Celldex Therapeutics, Inc. CLDX | $10.62M | 0.38 | 253,000 | New | +$10.62M | 0.06 | |
Denali Therapeutics Inc. DNLI | $10.32M | 0.35 | 502,899 | -37.37% | -$6.16M | 0.06 | |
Amicus Therapeutics, Inc. FOLD | $11.92M | 0.34 | 1.01M | -50.07% | -$11.95M | 0.06 | |
Xenon Pharmaceuticals Inc. XENE | $10.91M | 0.34 | 253,387 | New | +$10.91M | 0.06 | |
Apogee Therapeutics, Inc. APGE | $10.13M | 0.26 | 152,500 | New | +$10.13M | 0.05 | |
Viking Therapeutics, Inc. VKTX | $20.82M | 0.23 | 253,863 | New | +$20.82M | 0.11 | |
Ultragenyx Pharmaceutical Inc. RARE | $8.31M | 0.21 | 177,932 | New | +$8.31M | 0.04 | |
Sea Limited SE | $12.76M | 0.04 | 237,500 | -36.16% | -$7.22M | 0.07 | |
BeiGene, Ltd. BGNE | $63.3M | 0.03 | 404,782 | +0.07% | +$47,229.78 | 0.34 |